Key facts
- Amira Health’s last known valuation is $12.0M (Jul 2023).
- It has raised $2.8M across 1 recorded rounds; the latest was Seed Round ($2.8M) in Oct 2022.
- Notable investors include Dorm Room Fund, Harvard Innovation Launch Lab, Matter (Consulting Services (B2B)), SBXi, E14 Fund — 10 tracked in total.
- Amira Health has filed 1 Form D with the SEC, most recently Jul 2023 ($2.8M sold to 17 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Amira Health
Funding rounds
1 roundsAbout Amira Health
Developer of a menopause care platform designed to relieve women's hot flashes and improve their sleep. The company's platform uses a combination of personalized data, artificial intelligence, and human expertise to provide women with customized treatment plans that are effective and easy to follow, enabling women to manage their menopause symptoms and improve their quality of life.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2020
- Employees
- 8
- Website
- amira.care/
- Ownership
- Privately Held (backing)
Amira Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amira Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amira Health in its N-PORT filings yet. We sweep new filings monthly.